-
to immigration timelines for non-EU candidates Number of Open Positions: 1 Pay: negotiable Application Deadline: 27.2.2026 EU Researcher Profile : R2/R3 About the Workplace Masaryk University is modern, dynamic
-
Mechanobiology section of Michal Masarik Laboratory, Faculty of Medicine, Masaryk University (Brno, Czech Republic) investigates how cytoskeletal organization and cellular mechanics influence cancer cell
-
Neurology at Masaryk University. The goal of our research group is to create robust computational frameworks with which to better understand how information is processed across the vast range of scales
-
well as bacteriophages infecting pathogenic bacteria. The Plevka Lab has access to cutting-edge cryo-EM equipment at our in-house core facility. Our work is supported by significant third-party funding, including an ERC
-
: The research group of prof. Michal Masařík is a biomedical laboratory dedicated to exploring the molecular mechanisms that drive cancer progression, with a particular emphasis on the tumour microenvironment (TME
-
of Masaryk University, Brno, Czech Republic invites excellent scientists to apply for a two-year POSTDOC POSITION in Cell Signaling Description: Postdoctoral position is available in laboratory of Pavel Krejci
-
genome-wide analysis of the Czech/European population analyzed within the Genome of Europe project, which is currently underway in our laboratory. The successful candidate should: Hold a Ph.D. or its
-
advertised for the Research Group of Karla Plevova – Genomics of Immune Cells , an interdisciplinary team of biologists and bioinformaticians exploring the complexity of the human genome, with a special focus
-
co-culture systems Have prior experience in molecular biology techniques, such as RNA sequencing, Western blotting, qPCR, immunocytochemistry, or live-cell imaging Show an aptitude for designing and
-
integrity. A strong background in molecular or cellular biology, signalling pathways, or molecular cancer research. A prior experience with melanoma biology and MAPK signalling pathways is beneficial, but it